Saharsh Davuluri takes over as CEO & MD of Neuland Laboratories
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The first of four planned modules at the new plant is expected to come online by summer 2026
The revenues this quarter are in line with the outlook we envisaged for the year
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Subscribe To Our Newsletter & Stay Updated